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The melanoma·inducing gene of Xiphophorus fish en· 
codes the Xmrk receptor tyrosine kinase. U sing a highly 
specific antiserum p~oduced against the recombinant 
receptor expressed with a baculovirus, it is shown that 
Xmrk is the most abundant phosphotyrosine protein in 
fish melanoma and thus highly activated in the tumors. 
Studies on a melanoma cellline revealed that these cells 
produce an activity that considerably stimulates recep· 
tor autophosphorylation. The stimulating activity in· 
duces receptor down-regulation and can be depleted 
from the melanoma cellsupernatant by the immobilized 
recombinant receptor protein. The fi.sh melanoma cells 
can thus be considered autocrine tumor cells providing 
a source for future purification and characterization of 
the Xmrk Iigand. 
In Xiphophorus, certain hybrid genotypes develop malignant 
melanoma at high incidence. Classical genetic analyses re-
vealed that the dominantly acting tumor-locus (Tu-locus) is 
causally responsible for neoplastic transformation of pigment 
cells (Ahuja andAnders, 1976). Feral fishin their natural habi-
tat are generally tumor-free due to the simultaneaus presence 
of a tumor suppressor locus (R) which inactivates Tu. It is the 
crossing conditioned elimination of the R-locus which Ieads to 
the uncontrolled activity of the Tu-locus in the hybrid fishes 
resulting in the development of malignant melanomas. 
The Th-locus encodes the gene for a receptor tyrosine kinase 
(Xiphophorus melanoma receptor kinase, Xmrk), which was 
shown to be the melanoma-inducing oncogene of Xiphophorus 
(Wittbrodt et al., 1989). Due to the loss of the suppressor, the 
Xmrk gene is deregulated in the hybrids. Its overexpression in 
pigment cells results in malignant melanomas (Adam et al., 
1993). Besides the oncogenic version ofXmrk from the 7U-locus, 
a second copy ofXmrk exists obviously representing the proto-
oncogene (Schartl, 1990; Adam et al., 1991). Xmrk codes for a 
protein with all of the structural features of subclass I receptor 
tyrosine kinases and shows highest similarity to the human 
EGF1-receptor (hEGF-R). It is a novel member of this gene 
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family and thus is predicted to bind a so far unknown growth 
factor. 
Receptor tyrosine kinases are a group of transmembrane cell 
surface receptors, which mediate their signaling function 
through the activation of an intracellular tyrosine kinase do-
main (Ullrich and Schlessinger, 1990; Schlessinger and Ullrich, 
1992). In the physiological situation, this activation results 
from the binding of the corresponding growth factor to the 
extracellular domain. The appropriate interactions of the Ii-
gand and the receptor warrant the normal function. Addition-
ally several receptor tyrosine kinases appear as crucial effec-
tors in the process of neoplastic transformation. Unscheduled 
activity of the tyrosine kinase domain is responsible for the 
proliferative capacity of the cancer cell (Ullrich and Schless-
inger, 1990). In a few cases the activation ofthe tyrosine kinase 
activity was found to be due to activating mutations in the 
extracellular domain and/or the transmembrane domain, ren-
dering receptor activity independent from the presence of the 
growth factor ( Bargman and Weinberg, 1988; Roussel et al., 
1988; Woolford et al., 1988). The most common cellular lesion in 
cancers where receptor tyrosine kinases are affected, however, 
is not mutational activation but receptor overexpression (Ull-
rich and Schlessinger, 1990). High receptor densities on cell 
surfaces could Iead to activation via receptor oligomerization. 
On the other band, many tumors and tumor-derived cell lines 
have been found to coexpress receptors and the corresponding 
growth factors (Sporn and Roberts, 1985; reviewed by Heidin et 
al. (1987)). This is interpreted as an autocrine mechanism of 
activation as proposed by Sporn and 1bdaro (1980). The func-
tional significance of the various observations for the primary 
steps in tumor development remains tobe elucidated. The Xi-
phophorus melanoma model offers a unique in uivo system to 
study the mechanisms involved in receptor tyrosine kinase-
mediated tumorigenesis. 
1b understand how overexpression of the Xmrk oncogene 
Ieads to neoplastic transformation of pigment cells and thus to 
the development of malignant melanoma in Xiphophorus, anal-
ysis of the biochemical properties of the Xmrk receptor tyrosine 
kinase and the ligand/receptor interaction as weil as the signal 
transduction pathway within the cell is required. We had 
shown previously that the Xmrk protein is indeed a functional 
receptor tyrosine kinase and that it carries an activating mu-
tation in its extracellular or transmembrane domain which 
Ieads to a low Ievel of constitutive tyrosine autophosphoryla-
tion. The intracellular Irinase domain can be stimulated to high 
activities when fused to the extracellular Iigand binding do-
ide gel electrophoresis; GST, glutathione S-transferase; PLC, phospho-
lipase C. 
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main of the human EGF-receptor and exposed to physiological 
concentrations of EGF or TGFa (Wittbrodt et al., 1992). In the 
experiments reported here, we have expressed a recombinant 
Xmrk protein at high Ievels using the baculovirus system and 
produced a highly specific antiserum against this protein. Us-
ing these tools, we can demoostrate that the autophosphoryla-
tion of Xmrk is stimulated very much above the constitutive 
level by a factor present in melanoma cell culture supematant. 
We conclude that the fish melanoma cells produce the physi-
ological Iigand of the Xmrk receptor in an autocrine manner 
and thus can be used as a source for the purification of this 
putative growth factor. 
EXPERIMENTAL PROCEDURES 
Generation of Recombinant Baculouirus-A deletion of all 5 '-noncod· 
ing sequences was introduced in the Xmrk cDNA (pBII G4; Wittbrodt et 
al., 1989) by in uitro mutagenesie (Bio-Rad Muta-Gene™ Phagemid In 
Vitro Mutageneais Kit, Bio-Rad). 
An oligonucleotide of 44 bases was synthesized with the 5'-part cor-
responding to bases 27-49 ofthe Xmrk cDNA(5' CCGCGCAGAAACTC-
CATGAAGATCTAGAGCGGCCGCCACCGCGG 3') and the 3'-part eor-
responding to bases 656-672 of the pBluescript KS II vector 
(Stratagene, La Jolla, CA). Thus, a deletion of 54 bases was introduced 
into pBII G4, creating a new unique Bglll site at the point of deletion 5 
bases upstream ofthe start codon (Fig. lA). The entire coding sequenee 
was isolated by restriction digest with Bglll and Dral and eloned into 
the BamH I site ofpAcYMl. Thus the plasmid pAcYM1mrk was derived 
(Fig. lB). 
Expression Constructs-For transient expression in human embry-
onie kidney fibroblasts (293 cells), the pRK5 Xmrk construct was used, 
whereas the CVN Xmrk construet was used for the production of the 
stably expressing baby hamster kidney eellline (BHK cells X12). Both 
plasmids have been described previously (Wittbrodt et al., 1992). 
7issue Culture, 'Jransfection and lnfection, and Stimulation of 
Cells-The fish melanoma cells (PSM eells; Wakamatsu, 1981) were 
eultured at 28 oc in F-12 medium (Gibeo BRL, Neu Isenburg, Ger-
many), supplemented with 10% fetal calf serum (Seromed, Biochrom 
KG, Berlin) and antibiotics. To obtain conditioned medium, the subcon-
fluent dishes were ineubated with serum-free medium for 24 h. After 
this incubation the supematant was immediately used for the stimu-
lation experiments. 
The human 293 embryonie kidney fibroblasts were cultured at 37 oc 
in Dulbecco•s modified Eagle•s medium (Gibeo BRL) containing 10% 
fetal calf serum and antibiotics. Transfeetion of these eells was done as 
deseribed by Chen and Okayama ( 1987). 
The baby hamster kidney cells (BHK X12) were cultivated in Dul-
beeco's modified Eagle's medium/F-12, 1:1, with 10% fetal calf serum 
and antibiotics at 37 °C. 
The Spodoptera frugiperda Sf9 eells were cultured at 28 oc in TC100 
medium (Gibco BRL). Maintenance and infeetion of these cells were 
done according to Summers and Smith (1988). The standard infeetion 
with the baculovirus was done at a multiplicity of infection of 10 in 
175-cm2 flasks. 
For stimulation, transfected 293 cells or the BHK cells were grown as 
monolayers on six-well plates. The medium was removed and substi-
tuted with 0.5 ml of conditioned medium. The incubation was routinely 
done for 10 min at 37 oc and 5% co2. The eells were lysed immediately 
afterwards, as described below. 
Tryptic Digestion-MNPVmrk-infected Sf9 cells were collected 68 h 
post-infection by low speed centrifugation at 1500 x g for 5 min, washed 
once with phosphate-buffered saline (PBS), and then resuspended in 
PBS. Trypsin and EDTA were added to final concentrations of 0.05 and 
0.02%, respectively. After incubating for 10 min at room temperature, 
the reaction was stopped by adding fetal calf serum to a final c~ncen­
tration of 20%. The cells were pelleted as above, washed with PBS, and 
finally resuspended in Iysis buffer and lysed as described below. 
Metabolie Labeling of Cells-To metabolically Iabel proteins, cells 
were transferred to labeling medium (methionine-free Dulbeeco's modi-
fied Eagle's medium, Gibco BRL) supplemented with 1% dialyzed fetal 
ealf serum and antibiotics. 50 )lCilml of [315S]methionine (Amersham, 
Braunschweig, Germany) was added. Cells were cultured in this me-
dium overnight and subsequently lysed as described below. 
Cell Lysis-MNPVmrk infeeted Sf9 cells were collected 68-70 h post-
infection by low speed centrifugation (1500 x g, 5 rnin). The cell pellet 
was washed twice with PBS and then resuspended in Iysis buffer (20 
mM Hepes, pH 7.5, 150 mM NaCI, 10% glycerol, 1% Triton X-100, 1.5 mM 
MgC12, 1 mM EGTA, 2 mM phenylmethylsulfonyl fluoride, 200 unitslml 
aprotinin), at a density of 1 x 107 cellslml. As the Xmrk-expressing Sf9 
eells were resistant to osmotic or moderate mechanicallysis procedures, 
the cell suspension was passed through a French press (SLM Amineo 
minicell, at a maximum pressure of 20,000 p.s.i.). PSM and 293 cells 
were lysed with the same buffer on the culture dishes by incubating on 
ice for 5 min. The supematant was then collected and incubated an-
other 5 min before removing the cell debris by centrifugation at 14,000 
x g for 5 min. For analyzing tyrosine phosphorylation, 100 mM NaF and 
0.2 mM sodium orthovanadate were added to the Iysis buffer. 
Immunization of Rabbits-Rabbits were immunized with the reeom-
binant Xmrk protein produced in MNPVmrk-infected Sf9 cells. The 
antigen was cut out of a Coomassie-stained preparative SDS gel, the gel 
slices were fragmented by passing through a metal mesh and an emul-
sion with an equal amount of Freund's adjuvant was formed by repeat-
edly passing the 1:1 mixture through an injection needle coupled to two 
syringes. For the primary injection, complete Freund's adjuvant was 
used, ineomplete adjuvant was used for all subsequent i(\jections. One-
hundred 111 of the emulsion were injected subcutaneously und er each leg 
of the rabbit and an intramusewar injection of 300 pl was placed into 
the muscle of eaeh rear leg. Secondary boosts were done at intervals of 
6 weeks, and the bleeding was done 10 days after the boosts. For all 
experiments described in this manuscript the serum amrk (K.2) was 
used without further purification procedures. 
Immunoprecipitation-For immunoprecipitation, lysates were di-
luted 1:3 in HNTG buffer (20 mM Hepes pH 7 .2, 150 mM NaCI, 10% 
glyeerol, 0.1% Triton X-100) containing phosphatase inhibitors (100 mM 
NaF and 0.2 mM sodium orthovanadate). Twenty pl ofprotein A-Sepha-
rose (Pharmacia, Freiburg, Germany) in a 1:1 slurry in HNTG and the 
appropriate amount of antiserum (either 5 pl of the polyclonal amrk 
serum or 1 Jll of the monoclonal aPY antibody) were added and incu-
bated at 4 °C for at least 3 h. The Sepharose was pelleted by brief 
centrifugation (5 s, 14,000 x g) and washed three times with HNTG. For 
SDS-PAGE analysis 50 }11 ofsample loading buffer were added. 
The anti-phosphotyrosine antibody (aPY) is a monoclonal antibody 
(clone 5E.2), which detects phosphorylated tyrosine residues. 
Analysis of Glycosylation-Lysates of MNPVmrk-infected Sf9 cells 
were immunoprecipitated with the amrk serum, the immunoprecipi-
tates were washed twice with HNTG buffer, and the Xmrk protein was 
eluted from the Sepharose by boiling in 30 }ll of elution buffer (50 mM 
Tris/HCI pH 6.8, 0.5% (w/v) SDS, 0.1 M ~mercaptoethanol) for 5 min. 'Ib 
10 Jll of the eluate, 5 }11 of endoglyeosidase H buffer (200 mM sodium 
citrate, pH 5.5), 5 }11 of endoglycosidase H (1 milliunitslpl, Boehringer, 
Mannheim, Germany), and phenylmethylsulfonyl fluoride to a final 
concentration of 1 Jlg/}11 were added. After an incubation at 37 °C for 16 
h, the proteins were analyzed by SDS-PAGE. 
Western Blotting-Using 0.2 M phosphate buffer, the proteins were 
eleetroblotted to nitroeellulose membranes (Schleicher & Schüll, Das-
sei, Gennany) by standard procedures. The membranes were blocked 
for 1 hat room temperature with NET-G (150 mM NaCl; 5 mM EDTA; 50 
mM Trisill Cl, pH 7 .4, 0.05% Triton X-100; 0.25% gelatin) with several 
changes ofthe buffar. After incubating filters with the primary antibody 
for 6 h at 4 oc and extensive washing for another hour (room tempera-
ture), the filtere were incubated with horseradish peroxidase-coupled 
anti-mause or anti-rabbit secondary antibodies for 1 h at 4 oc and then 
washed again as above. The detection of bound antibodies was done 
with the nonradioactive ECL aystem (Amersham). 
Preparation of the Ligand Affinity Matri.x-The glutathione 
S-transferase/SH2 fusion protein (GST-SH2) was produced in Esch-
erichia coli XLlblue transformed with the expression construct I (Rotin 
et al., 1992), containing nucleotides 1697-2633 of the human PLC-y, 
which comprises the two SH2 and the SH3 domains. Isolation of the 
fusion protein was done as described by Rotin et al. (1992). It was 
purified by adsorption to glutathione-Sepharose (Phannacia), and 
stored as a suspension in PBS. The recombinant Xmrk receptor was 
bound to this matrix by incubation of the Sepharose with the cleared 
lysate of infected Sf9 cells at 4 oc for 2 h. The Sepharose was then 
pelleted by low speed eentrifugation and washed three times with PBS. 
For the depletion experiment, the Sepharose was incubated with the 
conditioned medium for 30 min at 4 oc. The supematant was separated 
from the Sepharose by centrifugation and used in the stimulation ex-
periment. 
RESULTS 
High Expression. of Recombinant Xmrk-To obtain a recom-
binant baculovirus that expresses the Xmrk gene, a full-length 
cDNA of the oncogene transcript (Wittbrodt et al., 1989) was 
B 
Ec:oAI 
Oral 
pBIIG4 
site directed 
in-vitro mutagenesis 
Bluescript ICS + 
Oral 
Oral Sacl 
EcoRI 
A 
EcoRI 
Dra VBamH I 
"bllllt" 
Autocrine Stimulation of Xmrk 
28 bp 26bp 
3'GGCGCCACCGCCGGCGAGAICTAGAAG~CTCAAAGACGCGCC5' 
Bglll 
Ec:oRI 
EcoRI 
pAcYM1 
Barrii I 
/ 
EcoRI 
pAcYM1 mrk 
Bgiii/BamH I 
EcoAI 
10425 
FIG. 1. Construction of the baculovirus expression vector. A, site-directed in vitro mutagenesis: schematic representation of the mu-
tagenized 5'-untranslated region ofthe Xmrk cDNA. B, Xmrk cDNA; 0, Bluescript KS+; m, oligonuclotide. B, cloning strategy for the baculovirus 
expression vector pAcYMlmrk. 
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FJG. 2. Expression of.Xmrk in MNPVmrk~infeeted sm cells. 1 X 
105 MNPVmrk-infected cells were lysed in Iysis buffer, cell debris· was 
removed by centrif'ugation; and the supematant was separated on an 
7.5% SDS-polyacrylamide gel. As controls uninfected or wild type virus-
infected ceHs were U$ed. The proteins were stained with Coomassie 
Brilliant Blue. 
cloned into the plasmid.vector pAcYMl (Matsuura et al., 1987). 
As the distance betweeil the viral polyhedrin promotor and the 
translational start is known to be a critical parameter to gain 
optimal expression (&mkin et al., 1988; Luckow and Summers, 
1989), all 5'-noncodingsequences of the Xmrk cDNA were de-
leted. This was achiev~d by introducing a suitable cloning site 
(Bglll) two nucleotides upstream of the start codon by oligo-
nucleotide-directed in uitro mutagenesis (Eig. lA). The result-
ing plasmid pAcYM1mrk (Fig. lB) was cotransfected together 
with wild type AcMNPV DNA into Sf9 cells. Recombinant vi-
ruses (MNPVmrk), where homologous recombination between 
sequences of the polyhedrin gene in the plasnlid and the wild 
type gene had occurred, were isolated and purified by two 
rounds of pJaque assay by taking advantage of a pplymerase 
chain reaction screening technique (Malitschek and Schartl, 
1991). 
Expression of Xmrk in insect cells infected with MNPVmrk 
was analyzed by SDS-PAGE .. Three additional proteins could be 
detected in whole celllysates of infected cells, which were ab-
sent in uninfected or wild type infected cells (Fig. 2). According 
to estimations from Goomassie-stained gels, they made up 
about 40% of the total cellular protein. The size of these pro-
teins was determined to be 155, 140, and 135 kDa. When sepa-
rating the proteins on minigels (8 cm x 7 cm, Biometra), the 
155 kD 
140/135 k 
0 
silver stain 
Fm .. 3. Analysis ofthe glycosylation ofrecombinantXmrk. The 
receptor was immunoprecipitated from the lysates of MNPVmrk-
infected sm cells with the amrk antiserum and eluted from protein 
A-Sepharose. The eluted protein was digested with endoglycosidase H 
and then analyzed by SDS-PAGE. As controls an aliquot of the eluate 
(0) and a sample where no enzyme had been added (-Endo R) were 
used. On this gel, the 135- and the 140-kDa protein could not be sepa· 
rated. The proteins were detected by silver staining. 
135- and 140-k.Da protein comigrated as a, single band. The 
predicted size of a nonposttranslationally modified Xmrk pro-
tein is in accordance with the smallest of the recombinant 
proteins. After treatment of the proteins with endoglycosidase 
H, only the 135-k.Da protein could be detected (Fig. 3). Thus, 
the 155-k.Da protein obviously is a glycosylated form of the 
recombinant Xmrk protein in which some or all of the predicted 
12 N-glycosylation sites in the extracellular domain are modi-
fied. 'lb ana1yze the subcellular localization of the recombinant 
protein, MNPVmrk-infected cells were treated with trypsin 
prior to Iysis. 1\vo proteins of approximately 100 and 60 kDa 
were the major products of this digestion (Fig. 4 ). The sizes of 
these digestion products are in perfect agreement with those 
expected for the correct localization of Xmrk as a transmem-
brane receptor. Cleavage at the trypsin site adjacent to the 
transmembrane domain would leave a predicted Xmrk frag-
ment of 59 k.Da consisting of the transmembrane domain and 
the intracellular part of the receptor. The 100-kDa fragment 
can be regarded as the product of a partial digest at another 
extracellular trypsin site. 
Abundant Expression of Xmrk in Melanoma-An Xmrk spe-
cific antiserum (amrk) was produced using the recombinant 
Xmrk protein from AMNVmrk-infected Sf9 cells. With this 
polyclon~:tl serum, it was shown that the Xmrk protein is very 
abundant in lysates of a melanoma-derived fish cellline (PSM 
cells), which overexpresses the Xmrk gene. The antiserum de-
tects the 160-kDa mature receptor, as weil as a 155-kDa un-
derglycosylated intracellular precursor (Fig. 5 and data not 
shown). This antiserumwas tested for cross-reactivity with the 
human EGF-receptor (hEGF-R). PSM ce1ls and the human car-
cinoma cellline (A431), which overexpress the EGF receptor, 
weremetabolically labeled with [35S]methionine, lysed, and im-
munoprecipitated with the amrk serum. In PSM cell extracts, 
the amrk se.rum precipitates both forms ofthe receptor(Fig. 6). 
No cross-reactivity of the serum with the hEGF-R could be 
detected in the lysates of the A431 cells (Fig. 6). On immuno-
blots of total cellular extracts of various fish tissues, the amrk 
serum detected Xmrk. as a very abundant protein in melanoma 
biopsies. The receptor could not be detected by these immuno-
logical methods in any ofthe normal tissues tested (Fig. 7A). 
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Fm. 4. Transmembrane localization of Xmrk expressed in Sf9 
cells. 1 x 105 MNPVmrk-infected cells were treated with trypsin prior 
to lysis. The cleared Jysates ofthese cells were analyzed by SDS-PAGE. 
Proteins were detected by silver staining. As a control, lysate of un-
treated cells was used. 
&ceptor Phosphorylation-The physiological activity of re-
ceptor tyrosine kinases is generally reflected by the state of 
phosphorylation of carboxyl-term.inal tyiosine residues. To in-
vestigate the state of a.ctivation ofthe Xmrk receptor, the phos-
phorylation on tyrosine was examined using a monoclonal an~· 
tibody directed against phosphotyrosine residues (aPY). We 
found that the Xmrk protein is the most abundant tyrosine 
phosphorylated protein in melanoma biopsies (Fig. 78 ). In the 
melanoma cell line (PSM cells), the mature 160-k:Da receptor 
proved to·be tyrosine-phosphorylated in contrast to the under-
glycosylated 155-kDa form (Figs. 5 and 6). In the Sf9 cells we 
found tyrosine phosphorylation on all isoforms of the receptor, 
but predominantly on the high molecular weight form (Fig. 5). 
Stimulatory Activity in Melanoma Cell Culture Super-
natants-To address the question whether the receptor activa-
tion in PSM cells may be due to some Iigand mediated autocrine 
stimulation, we inc:ubated Xmrk-expressing human 293 cells 
with PSM conditioned medium prior to Iysis (Fig. 8). A signifi-
cant enhancement ofthetyrosine phosphorylation ofthe recep-
tor compared with untreated cells or cells incubated with non-
conditioned growth medium was observed. The same 
stimulation was detected in BHK cells stably expressing Xmrk. 
A time course experiment revealed that this activation is maxi-
mal after 20 min of incubation and decreases at incubation 
times of more than 30 min. (Fig. 9). 
To show that the stimulating activity in the supernatant can 
bind specifically to the Xmrk receptor., we depleted this activity 
from the conditioned medium using the recombinant receptor 
PSM Sf9mrk 
r---------~ •• ~--------~ 
160kD > 
<155k0 
FIG. 5. Tyrosine phosphorylation of different receptor iso-
forms. PSM cells and MNPVmrk-infected Sffi ·cel1s were lysed in 
Laemmli buffer, separated on 7.5% polyacrylamide gels, and blotted. 
The blots were immunoprobed with amrk serum or the aPY antibody. 
Xmrk ~ ..... hEGF-R 
FJG. 6. Immunoprecipitation of Xmrk or hEGFR with amrk or 
aPY antibody. PSM cells or A431 cells were labeled,.in viuo with 
[ 36S]methionine and lysed. The lysates were immunoprecipitated with 
amrk or aPY. The precipitates were analyzed by SOS-PAGE. In the 
human cell line, the amrk serum precipitates a protein of 130 kDa, 
which could not be identified so far. 
as an affiriity matrix. To immobilize the receptor, we used a 
glutathione S-transferase (GST) fusion protein with the SH2 
domain of the human PLC-y (Rotin et al., 1992). It has been 
shown that the SH2 domain of PLCy binds tightly to Xmrk by 
interacting with the COOH-terminal autophosphorylation 
sites.2 The fusion protein was attached to the glutathione-
Sepharose, and the receptor was then absorbed to this. matrix. 
By incubating the cell culture supematant with this matrix 
prior to the stimulation experiment, the stimulatory activity 
was depleted very efficiently. Depletion with GST·BH2 matrix 
2 C. Wellbrock, personal communication. 
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Fm. 7. Overexpression and activation of the Xm.r,k receptor in fish melanoma. Celllysates of tissue biopsies were prepared and separated 
on SDS-polyacrylan:tide gels. The proteins were transferred to nitrocelluJose membrane and detected with either the amrk serum (A) or the cxPY 
antibody (B). 
293 mrk mock 
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FIG. 8. Stimulation ofreceptor autophosphorylation with con· 
ditioned medium of the melanoma cell line (PSM). Xmrk and 
mock-transfected 293 cells were PJ,etabolically labeled with [35S]methi-
onine and eitb.er treated with PSM-conditioned medium. ( +) or with pure 
growth medium (-) prior to lysis. The lysates were immunoprecipitated 
with aPY and the precipitates were analyzed by SDS-PAGE. 
alone (i.e. without:Xmrk receptor) showed no negative effect on 
the stimulation (Fig. 10). 
DISCUSSION 
In order to characterize the biochemical fu.nctions and sig-
naling properlies of the Xmrk receptor tyrosine kinase as we1l 
as to approach the identification of its ligand, we have overex-
pressed the protein using the baculovirus expression system. 
We chose the baculovirus system, because it has proven to be 
very efficient for the expression of eukaryotic proteins and par-
ticularly for transmembrane receptors (Greenfield et al., 1988). 
The Xmrk protein expressed in MNPVmrk-infected Sf9 cells 
makes up about 40% of the total cellular protein. This is very 
close to the optim.um level of protein expression that can be 
expected with baculovirus vectors. The polyhedrin product of 
the gene whose promotor we used for expression accumulates 
to a level of about 50% of the total cellular protein Ievel in wild 
type virus-infected cells (Luckow and Summers, 1988). In our 
attempts to analyze the Xmrk prötein expressed in the Sf9 
cells, we could show that the signal peptide of the fish receptor 
is obviously correctly recognized and that most of the produced 
protein is integrated into the plasma membrane of the insect 
cells. This led to a very high protein content in the membrane, 
which rendered the infected cells very resistant to standard 
lysis procedures. 
It has been. shown that N-glycosylated proteins produced in 
insect cells are of the high mannose type and that conversion to 
complexN-linked oligosaccharides generally does not occur (re-
viewed by O'Reilly et al. (1992)). This would explain the ob-
served size difference of 5 k:Da between the native Xm:rk from 
fish melanoma cells and the recombinant Xmrk protein ex-
pressed in Sf9 cells. By digestion of the recombinant Xmrk 
protein with endoglycosidase H, it was demonstrated that the 
155-kDa and very likely the 140-kDa species as well are par-
tially glycosylated forms of the high mannose type and that the 
135-kDa species is the unglycosylated precu.rsor. In the PSM 
cells, we also found a highmannosetype precursor of the re-
ceptor witb a size of 155 kDa, which is not integrated into the 
membrane and subsequently is not phosphorylated. Tbe shift 
in electrophoretic mobility of the mature receptor to an appar-
ent molecular weight of 160,000 is obviously due to the proc-
essing oftbe high mannose chains to complex oligosaccharides, 
similar to what bas been observed for the EGF receptor (Man-
gelsdorf Soderquist and Carpenter, 1984). The tyrosine phos-
phorylation of the recombinant receptor in the insect cells is 
very likely caused by the extreme overexpression and the very 
high receptor density in the membrane of the expressing Sf9 
cells, which would result in a Iigand independent transphos-
phorylation of the receptors. 
With the amrk serum, the Xmrk proteinwas detected only in 
melanoma biopsies, although the 'proto-oncogene is transcribed 
at low levels in several nontumoraus tissues, like skin, gills, 
and brain (Adam et al., 1991). 3 To decide whether the failure to 
detectthe protein product is due to the limited sensitivity ofthe 
immunoblotting technique or to some posttranscriptional regu-
lation, further experi.ments are required. For the EGF receptor, 
3 N. Dimitrijevic, personal communication. 
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[min] 
FIG. 9. Timecourse of receptor au-
tophosphorylation. BHK cells stably 
expressing Xmrk were treated with con-
ditioned medium from the PSM cells for 
different time periods prior to Iysis. The 
cells wete lysed in sample bmfer, and the 
proteins Were separated On a SDS~polyac­
ryla.mide gel. The gel was blotted and im-
munoprobed with the mAb aPY. 
160 kD Xmrk ~ 
blotting antibody aPy 
•xmrk 
mock pRKSmrk 
transfected 293 cens 
Detectfon: cxPY 
Fio. 10. Binding of the Xmrk stimulating activity to immobilized recombinant receptor protein. Mock"transfected or pRK5 Xmrk-
transfected 293 cells were stimulated either with ultrafiltration concentrated (5 x PSM) or unconcentrated (1 x PSM) conditioned PSM medium. 
Where indicated, the conditioned medium was depleted through a ligand-affinity matrix. As controls, unconditioned medium (medium) an.d 1 x 
PSM that was depleted over a glutathione-Sepharose column where only the GST"PLCy fusion prötein, but not the receptor, had been adsorbed 
to (control) were used. The proteins were separated by SDS~PAGE, blotted, and detected with the aPY antibody. 
it was shown that stimula:tion with EGF leads to higher recep-
tor mRNA levels in the cells and that this up-regulation of the 
transcript is a posttranscriptional effect (Clark et al., 1985; 
Earp et al., 1986) and might be due to high er mRNA stability in 
stimulated cells (Jinno et al., 1988). With regard of these re-
sults, one could speculate that an efficient translation of the 
Xmrk gene can only occur in tissues expressing a suitable li-
gand. 
To detect the presence of a putative ligand, we measured the 
activation of the receptor by e?Camining the state of autophos• 
phorylation. In a previous study, we could show that there is a 
basal level of rec~ptot autophosphorylation when the XJnrk 
gene is expressed in heterologous systems, such as transient 
expression in hl:);man embryonie kidney fibroblasts (293 cells) 
and stable expression in BHK cells. We could demonstrate that 
this basal activity is due to an activating mutation in the ex-
tracellular or transmembrane part ofthe receptor (Wittbrodt et 
al., 1992). However, this activating mutation in the native re-
ceptor is not sufficient to lead to a transformation of 3T3 cells 
in the focus formation assay (Wittbrodt et al., 1992). In the 
same system, a hEGFRJXmrk chimera in the presence of EGF 
is a highly potent oncoprotein. To explain the high transform-
ing potential of Xmrk in the Xiphophorus melanoma system, 
another mechanism of activation must be postu1ated. In the 
melanoma-derived PSM cellline of Xiphophorus, the receptor 
was determined tobe highly autophosphorylated, sqggesting 
that autocrine receptor stimulation due to production of the 
physiologicalligand may be such an additional mechanism. We 
demonstrated that the PSM cells secrete a factor into the cel1 
culture medium that can significa:ntly enhance the ba:sallevel 
of activation in the heterologous assay systems. This factor not 
only induces receptor phosphorylation, but also receptor down-
regulation as was seen after prolonged incubation of expressing 
cells w.ith the conditioned medium. Furthetmore, the stimu)at-
ing activity could be depleted very specificallyand efficiently by 
incubation with the iminobilized recombinant receptor. Taken· 
together, these data strongly suggest that the PSM cells pro-
duce the physiological ligand for the Xmrk receptor and grow 
autonomously via an autocrine pathway. Such autocrine sys-
tems have been identifi.ed in normal as weil as transformed 
cells (reviewed in Sporn and Roberts (1985); Heidin et al., 
1987). The expression ofthe growth factors in transformed cells 
may be caused by different mechanisms. In an indirect auto-
crine pathway, the expression of a growth factor is triggered by 
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intracellular oncogenes at the transcriptional Ievel. This was 
shown for the p21K·I'CU_ or p3711108-dependent production of trans-
fonning growth factor-a in Mo-MSV and Ki-MSV transformed 
cells (Ozanne et al., 1980; Kaplan et al., 1982). It might be that 
the overexpression together with the basal activity ofthe Xmrk 
receptor Ieads to a comparable up-regulation of the production 
of the Xmrk ligand in the PSM cells. On the other band, trans-
formation of PDGF-receptor-expressing cells by the sis onco-
gene, which encodes a PDGF-Iike molecule (Doolittle et al., 
1983; Watemeldet al., 1983) is an example of a direct autocrine 
pathway. This autocrine receptor activation is responsible for 
cell transformation of simian sarcoma virus-infected cells as 
was shown by the antagonistic action of PDGF antibodies 
(Johnsson et al., 1985). But the expression of growth factors in 
tumor cells may also reflect a normal function of the progenitor 
cell. Many normal cell types are known to produce growth 
factors in an autocrine manner, dependent on their stage of 
differentiation and activation. Examples include transfonning 
growth factor-a in murine embryonal cells (Lee et al., 1985) and 
PDGF in endothelial cells and activated macrophages (Jaye et 
al., 1985; Martinet et al., 1986). It seems most likely that in the 
PSM cells the expression of the Xmrk-specific growth factor 
represents a certain developmental stage of the normal coun-
terpart of the melanoma cells as none of the additional onco-
genic conversions <Iike retrovirus infection) described so far in 
autocrine tumor cell systems has been found in this cell line. 
Although in Xiphophorus melanoma fonnation, the tran-
scriptional activation of a single gene, the Xmrk gene, is nec-
essary and sufficient to initiate neoplastic transformation of 
pigment cells, there are additional factors which must be pre-
sent for the development of the malignant phenotype. The Ii-
gand ofXmrk is one of such additional factors. ldentification of 
this protein will help to elucidate the multistep nature of the 
Xmrk-initiated tumorigenesis in Xiphophorus. The PSM cells 
can serve as a source for the purification of this new growth 
factor. The analysis of its expression pattem and biochemical 
functions is expected to contribute to an understanding of au-
tocrine activation processes in tumor formation. 
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